Provided by Tiger Trade Technology Pte. Ltd.

Nuvation Bio, Inc.

6.14
+0.35506.14%
Volume:2.69M
Turnover:16.30M
Market Cap:2.15B
PE:-13.99
High:6.15
Open:5.96
Low:5.92
Close:5.78
52wk High:9.75
52wk Low:2.99
Shares:351.12M
Float Shares:264.00M
Volume Ratio:0.86
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4387
EPS(LYR):-0.6000
ROE:-47.81%
ROA:-12.36%
PB:8.49
PE(LYR):-10.22

Loading ...

Nuvation Bio announces FDA approval of sNDA for Ibtrozi

TIPRANKS
·
Yesterday

Nuvation Bio Wins FDA Nod to Update Ibtrozi Label with 49.7-Month Response Duration in TRUST-I Study

Reuters
·
Yesterday

Nuvation Bio Announces FDA Approval of Supplemental New Drug Application for Ibtrozi® (Taletrectinib) with Updated Duration of Response in Tki-NaÏVe Advanced Ros1-Positive Non-Small Cell Lung Cancer

THOMSON REUTERS
·
Yesterday

Nuvation Bio - no Changes to Ibtrozi Safety Labeling; no New Safety Signals Identified

THOMSON REUTERS
·
Yesterday

Nuvation Bio Price Target Maintained with a $11.00/Share by Wedbush

Dow Jones
·
Sep 16

Nuvation Bio CEO, CFO to Present at Citi Biopharma Conference Fireside Chat

Reuters
·
Sep 03

Nuvation Bio CSO Gary Hattersley Disposes of Class a Common Shares Worth $709,240

Reuters
·
Aug 22

Cantor Fitzgerald Initiates Nuvation Bio at Overweight

MT Newswires Live
·
Aug 21

Nuvation Bio Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
Aug 21

Nuvation Bio initiated with an Overweight at Cantor Fitzgerald

TIPRANKS
·
Aug 21

Nuvation Bio Wins FDA Fast-Track Status for Safusidenib in IDH1-Mutant Glioma

Reuters
·
Aug 20

Nuvation Bio Granted FDA Fast Track Designation for Safusidenib for Treatment of Idh1-Mutant Glioma

THOMSON REUTERS
·
Aug 20

Nuvation Bio Inc. : JP Morgan Initiates Coverage with Overweight Rating; Target Price $13

THOMSON REUTERS
·
Aug 18

Power Solutions International And 2 More Growth Stocks With Strong Insider Ownership

Simply Wall St.
·
Aug 11

RBC Adjusts PT on Nuvation Bio to $20 From $19, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Analysts Have Conflicting Sentiments on These Healthcare Companies: Intellia Therapeutics (NTLA), Haemonetics (HAE) and Nuvation Bio (NUVB)

TIPRANKS
·
Aug 07

Nuvation Bio Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Nuvation Bio Posts Corporate Presentation Highlighting Ibtrozi ROS1 Lung Cancer Franchise

Reuters
·
Aug 06

Earnings Flash (NUVB) Nuvation Bio Posts Q2 Net Loss of $0.18 per Share, vs. FactSet Est of $0.15 Loss

MT Newswires Live
·
Aug 06

Nuvation Bio Q2 Revenue Beats Estimates on Ibtrozi Growth

Reuters
·
Aug 06